232 related articles for article (PubMed ID: 22580034)
21. Invasive pulmonary aspergillosis treatment duration in haematology patients in Europe: An EFISG, IDWP-EBMT, EORTC-IDG and SEIFEM survey.
Lanternier F; Seidel D; Pagano L; Styczynski J; Mikulska M; Pulcini C; Maertens J; Munoz P; Garcia-Vidal C; Rijnders B; Arendrup MC; Sabino R; Verissimo C; Gaustad P; Klimko N; Arikan-Akdagli S; Arsic V; Barac A; Skiada A; Klingspor L; Herbrecht R; Donnelly P; Cornely OA; Lass-Flörl C; Lortholary O
Mycoses; 2020 May; 63(5):420-429. PubMed ID: 32009262
[TBL] [Abstract][Full Text] [Related]
22. Mixed mold infection with
Bellanger AP; Navellou JC; Lepiller Q; Brion A; Brunel AS; Millon L; Berceanu A
Infect Dis Now; 2021 Oct; 51(7):633-635. PubMed ID: 33527098
[No Abstract] [Full Text] [Related]
23. Diagnosing Invasive Pulmonary Aspergillosis in Hematology Patients: a Retrospective Multicenter Evaluation of a Novel Lateral Flow Device.
Mercier T; Schauwvlieghe A; de Kort E; Dunbar A; Reynders M; Guldentops E; Rijnders B; Verweij PE; Lagrou K; Maertens J
J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30651395
[TBL] [Abstract][Full Text] [Related]
24. [Clinical factors associated with invasive pulmonary aspergillosis in patients with chronic pneumopathies and respiratory isolation of Aspergillus spp].
Castón JJ; Linares MJ; Rivero A; Casal M; Torre-Cisneros J
Med Clin (Barc); 2012 Dec; 139(15):668-71. PubMed ID: 23103103
[TBL] [Abstract][Full Text] [Related]
25. Clinical Features and Prognosis of Invasive Pulmonary Aspergillosis in Korean Children with Hematologic/Oncologic Diseases.
Han SB; Kim SK; Bae EY; Lee JW; Yoon JS; Chung NG; Cho B; Jeong DC; Kang JH; Kim HK; Lee DG; Lee HS; Im SA
J Korean Med Sci; 2015 Aug; 30(8):1121-8. PubMed ID: 26240490
[TBL] [Abstract][Full Text] [Related]
26. Invasive pulmonary aspergillosis in patients with influenza infection: report of two cases and systematic review of the literature.
Alshabani K; Haq A; Miyakawa R; Palla M; Soubani AO
Expert Rev Respir Med; 2015 Feb; 9(1):89-96. PubMed ID: 25547335
[TBL] [Abstract][Full Text] [Related]
27. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.
Lahmer T; Neuenhahn M; Held J; Rasch S; Schmid RM; Huber W
J Crit Care; 2016 Dec; 36():259-264. PubMed ID: 27475024
[TBL] [Abstract][Full Text] [Related]
28. COVID-19-associated pulmonary aspergillosis (CAPA): identification of Aspergillus species and determination of antifungal susceptibility profiles.
Ozturk A; Bozok T; Erdogan M; Ibrahim BM; Bozok TS
Folia Microbiol (Praha); 2023 Dec; 68(6):951-959. PubMed ID: 37294497
[TBL] [Abstract][Full Text] [Related]
29. CT of invasive pulmonary aspergillosis (IPA) in cases with hematologic malignancy: Comparison of CT features in the group classified by the severity of neutropenia and underlying disease.
Yanagawa N; Sakai F; Doki N; Sekiya N
Eur J Radiol; 2020 Oct; 131():109042. PubMed ID: 32709370
[TBL] [Abstract][Full Text] [Related]
30. Comparison of Serum Galactomannan and 1,3-Beta-D-Glucan Determination for Early Detection of Invasive Pulmonary Aspergillosis in Critically Ill Patients with Hematological Malignancies and Septic Shock.
Lahmer T; Rasch S; Schnappauf C; Beitz A; Schmid RM; Huber W
Mycopathologia; 2016 Aug; 181(7-8):505-11. PubMed ID: 27142781
[TBL] [Abstract][Full Text] [Related]
31. Invasive pulmonary aspergillosis due to Aspergillus lentulus in an adult patient: A case report and literature review.
Yagi K; Ushikubo M; Maeshima A; Konishi M; Fujimoto K; Tsukamoto M; Araki K; Kamei K; Oyamada Y; Oshima H
J Infect Chemother; 2019 Jul; 25(7):547-551. PubMed ID: 30824299
[TBL] [Abstract][Full Text] [Related]
32. A case of invasive pulmonary aspergillosis diagnosed by transbronchial lung biopsy during treatment for diabetic ketoacidosis in a type 1 diabetic patient.
Watanabe N; Saito K; Kiritani A; Fujimoto S; Yamanaka Y; Fujisaki I; Hosoda C; Miyagawa H; Seki Y; Kinoshita A; Takeda H; Endo Y; Kuwano K
J Infect Chemother; 2020 Feb; 26(2):274-278. PubMed ID: 31542205
[TBL] [Abstract][Full Text] [Related]
33. Serum galactomannan index for early prediction of mortality in immunocompromised children with invasive pulmonary aspergillosis.
Han SB; Kim SK; Lee JW; Yoon JS; Chung NG; Cho B; Jeong DC; Kang JH; Kim HK; Lee DG; Lee HS; Im SA
BMC Infect Dis; 2015 Jul; 15():271. PubMed ID: 26168914
[TBL] [Abstract][Full Text] [Related]
34. Galactomannan testing of bronchoalveolar lavage fluid is useful for diagnosis of invasive pulmonary aspergillosis in hematology patients.
Hsu LY; Ding Y; Phua J; Koh LP; Chan DS; Khoo KL; Tambyah PA
BMC Infect Dis; 2010 Mar; 10():44. PubMed ID: 20199673
[TBL] [Abstract][Full Text] [Related]
35. Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis.
Danpornprasert P; Foongladda S; Tscheikuna J
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S86-93. PubMed ID: 20364562
[TBL] [Abstract][Full Text] [Related]
36. Voriconazole Resistance and Mortality in Invasive Aspergillosis: A Multicenter Retrospective Cohort Study.
Lestrade PP; Bentvelsen RG; Schauwvlieghe AFAD; Schalekamp S; van der Velden WJFM; Kuiper EJ; van Paassen J; van der Hoven B; van der Lee HA; Melchers WJG; de Haan AF; van der Hoeven HL; Rijnders BJA; van der Beek MT; Verweij PE
Clin Infect Dis; 2019 Apr; 68(9):1463-1471. PubMed ID: 30307492
[TBL] [Abstract][Full Text] [Related]
37. Utility of serum galactomannan antigen testing combined with chest computed tomography for early diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies with febrile neutropenia after antifungal drug treatment.
Wang X; Guo G; Cai R; He P; Zhang M
J Int Med Res; 2019 Feb; 47(2):783-790. PubMed ID: 30477369
[TBL] [Abstract][Full Text] [Related]
38. Drivers and impact of antifungal therapy in critically ill patients with Aspergillus-positive respiratory tract cultures.
Paiva JA; Mergulhão P; Gomes A; Taccone FS; Van den Abeele AM; Bulpa P; Misset B; Meersseman W; Dimopoulos G; Rello J; Vogelaers D; Blot S
Int J Antimicrob Agents; 2017 Oct; 50(4):529-535. PubMed ID: 28669830
[TBL] [Abstract][Full Text] [Related]
39. Tracheobronchial manifestations of Aspergillus infections.
Krenke R; Grabczak EM
ScientificWorldJournal; 2011; 11():2310-29. PubMed ID: 22194666
[TBL] [Abstract][Full Text] [Related]
40. Direct comparison of galactomannan performance in concurrent serum and bronchoalveolar lavage samples in immunocompromised patients at risk for invasive pulmonary aspergillosis.
Boch T; Buchheidt D; Spiess B; Miethke T; Hofmann WK; Reinwald M
Mycoses; 2016 Feb; 59(2):80-5. PubMed ID: 26627577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
